EMILEE ODOM: Open Payments
NPI 1417306580 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,517 in 107 payments from 13 companies in 2025. Trend: 2023 $1,625 · 2024 $1,671 · 2025 $1,517
Food & beverage: $1,517
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 20 | $358 |
| UCB, Inc. | 16 | $198 |
| Lilly USA, LLC | 15 | $175 |
| Janssen Biotech, Inc. | 14 | $166 |
| E.R. Squibb & Sons, L.L.C. | 17 | $144 |
| GENZYME CORPORATION | 5 | $117 |
| ABBVIE INC. | 4 | $74 |
| Organon LLC | 6 | $70 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $65 |
| LEO Pharma Inc. | 2 | $47 |
Products named: COSENTYX, Bimzelx, TALTZ, TREMFYA, Sotyktu, DUPIXENT, Rhapsido, SKYRIZI.
Industry payments across AR — which companies pay providers there.
